Losartan attenuates endothelial hyperpermeability responses to VPF and high glucose but not angiotensin II

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Diabetologia

• Publication date

  2002-02-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/s00125-001-0748-7PMID 11942316
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Angiotensin converting enzyme inhibition reduces retinal overexpression of vascular endothelial growth factor and hyperpermeability in experimental diabetes

  2000cited by this paper
• Endothelial cell monolayers as a model system to investigate dengue shock syndrome.

  1998cited by this paper
• Nitric oxide, a new second messenger involved in the action of angiotensin II on neuronal differentiation of NG108-15 cells.

  1998cited by this paper
• Factors regulating the expression of vascular permeability/vascular endothelial growth factor by human vascular tissues

  1997cited by this paper
• Increased transendothelial permeation of albumin by high glucose concentration.

  1995cited by this paper
• Angiotensin II increases vascular permeability factor gene expression by human vascular smooth muscle cells.

  1995cited by this paper
• Inflammatory agonists that increase microvascular permeability in vivo stimulate cultured pulmonary microvessel endothelial cell contraction

  1990cited by this paper

• Protein kinase C-beta inhibition and diabetic microangiopathy: effects on endothelial permeability responses in vitro.

  2004cites this paper
• Rapid Improvement of Acute Pulmonary Edema with Angiotensin Converting Enzyme Inhibitor under Hemodialysis in a Patient with Renovascular Disease

  2004cites this paper
• Rosiglitazone and pulmonary oedema: an acute dose-dependent effect on human endothelial cell permeability

  2003cites this paper
• Microalbuminuria: a common, independent cardiovascular risk factor, especially but not exclusively in type 2 diabetes.

  2003cites this paper